The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre

References

• Turner PJ. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates. Diagn Microbiol Infect Dis 2009;63:217–22.
   PubMed Web of Science ®Google Scholar
• Souli M, Galani I, Giamarellou H. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 2008;13. pii: 19045.
   PubMedGoogle Scholar
• Rhomberg PR, Jones RN. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008). Diagn Microbiol Infect Dis 2009;65:414–26.
   PubMed Web of Science ®Google Scholar
• Wang H, Chen M, Ni Y, Liu Y, Sun H, Yu Y, . Antimicrobial resistance among clinical isolates from the Chinese Meropenem Surveillance Study (CMSS), 2003–2008. Int J Antimicrob Agents 2010;35:227–34.
   PubMed Web of Science ®Google Scholar
• Fujimura T, Anan N, Sugimori G, Watanabe T, Jinushi Y, Yoshida I, . Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agents. Int J Antimicrob Agents 2009;34:523–8.
   PubMed Web of Science ®Google Scholar
• Livermore DM. Of Pseudomonas, porins, pumps and carbapenems. J Antimicrob Chemother 2001;47:247–50.
   PubMed Web of Science ®Google Scholar
• Walsh TR. Clinically significant carbapenemases: an update. Curr Opin Infect Dis 2008;21:367–71.
   PubMed Web of Science ®Google Scholar
• Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 2005;18:306–25.
   PubMed Web of Science ®Google Scholar
• Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs 2008;17:131–43.
   PubMed Web of Science ®Google Scholar
• Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005;11(Suppl):17–32.
   PubMedGoogle Scholar
• Laupland KB, Parkins MD, Church DL, Gregson DB, Louie TJ, Conly JM, . Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains. J Infect Dis 2005;192:1606–12.
   PubMed Web of Science ®Google Scholar
• Zavascki AP, Barth AL, Gonçalves AL, Moro AL, Fernandes JF, Martins AF, . The influence of metallo-β-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 2006;58:387–92.
   PubMed Web of Science ®Google Scholar
• Pena C, Suarez C, Tubau F, Gutierrez O, Domínguez A, Oliver A, . Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect 2007;13:1026–9.
   PubMed Web of Science ®Google Scholar
• Pitout JD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large centralized laboratory. J Clin Microbiol 2005;43:3129–35.
   PubMed Web of Science ®Google Scholar
• Picao RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE, . Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol 2008;46:2028–37.
   PubMed Web of Science ®Google Scholar
• Masuda G, Tomioka S, Hasegawa M. Detection of beta-lactamase production by Gram-negative bacteria. J Antibiot (Tokyo) 1976;29:662–4.
   PubMed Web of Science ®Google Scholar
• Smith Moland E, Hanson ND, Herrera VL, Black JA, Lockhart TJ, Hossain A, . Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother 2003;51:711–4.
   PubMed Web of Science ®Google Scholar
• Woodford N. Rapid characterization of beta-lactamases by multiplex PCR. Methods Mol Biol 2010;642:181–92.
   PubMedGoogle Scholar
• Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002;40: 3798–801.
   PubMed Web of Science ®Google Scholar
• Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003;41:4623–9.
   PubMed Web of Science ®Google Scholar
• Oh EJ, Lee S, Park YJ, Park JJ, Park K, Kim SI, . Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean university hospital and comparison of screening methods for detecting metallo-beta-lactamase. J Microbiol Methods 2003; 54:411–8.
   PubMed Web of Science ®Google Scholar
• Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A. Evaluation of a new Etest for detecting metallo-beta-lactamases in routine clinical testing. J Clin Microbiol 2002;40:2755–9.
   PubMed Web of Science ®Google Scholar
• Berges L, Rodriguez-Villalobos H, Deplano A, Struelens MJ. Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa. J Antimicrob Chemother 2007;59: 812–3.
   PubMed Web of Science ®Google Scholar
• Ratkai C, Quinteira S, Grosso F, Monteiro N, Nagy E, Peixe L. Controlling for false positives: interpreting MBL Etest and MBL combined disc test for the detection of metallo-beta-lactamases. J Antimicrob Chemother 2009;64:657–8.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 18th informational supplement M100-S18. Wayne, PA: CLSI; 2008.
   Google Scholar
• Pitout JD, Le PG, Moore KL, Church DL, Gregson DB. Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory. Clin Microbiol Infect 2010;16:165–70.
   PubMed Web of Science ®Google Scholar
• Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, . Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007;57:315–8.
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Walsh KE, Walker VJ. Identification of extended-spectrum, AmpC, and carbapenem-hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests. J Clin Microbiol 2006;44:1971–6.
   PubMed Web of Science ®Google Scholar
• Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005;43:4163–7.
   PubMed Web of Science ®Google Scholar